Investigational Drug Information for Tegafur
✉ Email this page to a colleague
What is the development status for investigational drug Tegafur?
Tegafur is an investigational drug.
There have been 158 clinical trials for Tegafur.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2014.
The most common disease conditions in clinical trials are Stomach Neoplasms, Adenocarcinoma, and Carcinoma. The leading clinical trial sponsors are Fudan University, Taiho Pharmaceutical Co., Ltd., and National Cancer Institute (NCI).
There are eight hundred and twenty-two US patents protecting this investigational drug and zero international patents.
Summary for Tegafur
| US Patents | 822 |
| International Patents | 17,106 |
| US Patent Applications | 6,586 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 418 |
| Clinical Trial Progress | Phase 3 (2014-09-01) |
| Vendors | 66 |
Recent Clinical Trials for Tegafur
| Title | Sponsor | Phase |
|---|---|---|
| Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) | Fifth Affiliated Hospital, Sun Yat-Sen University | Phase 2 |
| Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) | Nanfang Hospital, Southern Medical University | Phase 2 |
| Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) | Wuhan University | Phase 2 |
Clinical Trial Summary for Tegafur
Top disease conditions for Tegafur
Top clinical trial sponsors for Tegafur
US Patents for Tegafur
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tegafur | ⤷ Sign Up | Heterocyclic compounds useful in the treatment of disease | Epigen Biosciences, Inc. (San Diego, CA) | ⤷ Sign Up |
| Tegafur | ⤷ Sign Up | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | ⤷ Sign Up |
| Tegafur | ⤷ Sign Up | Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same | Protalix Ltd. (Carmiel, IL) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tegafur
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tegafur | Australia | AU2014232383 | 2033-03-15 | ⤷ Sign Up |
| Tegafur | Australia | AU2019202731 | 2033-03-15 | ⤷ Sign Up |
| Tegafur | Australia | AU2019288275 | 2033-03-15 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
